StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$16.61−0.17 (-1.01%)

Close on Nov 19, 2026Market cap $1.89BP/E –Yield –

Immunome gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Immunome

Immunome has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immunome figures

See a number that looks wrong?